Magali Herrant
Impact in
- Hematology top 5%
- Chronic Myeloid Leukemia Treatments
- Genetics top 10%
- Chronic Lymphocytic Leukemia Research
Papers in
-
- Cell death mechanisms and regulation 4
- Ubiquitin and proteasome pathways 3
- RNA Interference and Gene Delivery 2
-
- Immunotherapy and Immune Responses 2
- T-cell and B-cell Immunology 2
- Immune Cell Function and Interaction 2
- Co-authors
- Patrick Auberger (11 shared papers)Frédéric Luciano (6 shared papers)Arnaud Jacquel (5 shared papers)Pascal Colosetti (3 shared papers)Gilles Pagès (2 shared papers)Sébastien Cagnol (1 shared paper)Nathalie Belhacène (3 shared papers)Sandrine Marchetti (2 shared papers)
- Journals
- Oncogene (4 papers)The FASEB Journal (2 papers)Leukemia (1 paper)European Journal of Immunology (1 paper)Neurodegenerative Diseases (1 paper)
- Partner nations
- FranceUnited StatesCanada
In The Last Decade
Magali Herrant
11 papers receiving 872 citations
Peers
Comparison fields: 5 of 75
- Hematology 176
- Genetics 97
- Molecular Biology 607
- Immunology 169
- Oncology 181
Countries citing papers authored by Magali Herrant
This map shows the geographic impact of Magali Herrant's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Magali Herrant with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Magali Herrant more than expected).
Fields of papers citing papers by Magali Herrant
This network shows the impact of papers produced by Magali Herrant. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Magali Herrant. The network helps show where Magali Herrant may publish in the future.
Co-authors
The 25 scholars most cited alongside Magali Herrant, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2003 | 396 | |
| 2 | 2004 | 149 | |
| 3 | 2003 | 106 | |
| 4 | 2005 | 68 | |
| 5 | 2002 | 38 | |
| 6 | 2006 | 32 | |
| 7 | 2002 | 29 | |
| 8 | 2003 | 22 | |
| 9 | 2004 | 21 | |
| 10 | 2002 | 19 | |
| 11 | 2007 | 3 |
About Magali Herrant
Magali Herrant is a scholar working on Molecular Biology, Immunology, Cancer Research, Infectious Diseases and Genetics, having authored 11 papers that have together received 883 indexed citations. Recurring topics across this work include Cell death mechanisms and regulation (4 papers), Ubiquitin and proteasome pathways (3 papers), Immunotherapy and Immune Responses (2 papers), T-cell and B-cell Immunology (2 papers), RNA Interference and Gene Delivery (2 papers), Immune Cell Function and Interaction (2 papers), Cancer Mechanisms and Therapy (1 paper) and Alzheimer's disease research and treatments (1 paper). The work is most often cited by research in Hematology (176 citations), Genetics (97 citations), Molecular Biology (607 citations), Immunology (169 citations) and Oncology (181 citations). Magali Herrant has collaborated with scholars based in France, United States and Canada. Frequent co-authors include Patrick Auberger, Frédéric Luciano, Arnaud Jacquel, Pascal Colosetti, Gilles Pagès, Sébastien Cagnol, Nathalie Belhacène, Sandrine Marchetti, Paul Hofman and Laurence Legros. Their work appears in journals such as Oncogene, The FASEB Journal, Leukemia, European Journal of Immunology and Neurodegenerative Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.